BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Undela K, Shah CS, Mothe RK. Statin use and risk of cancer: An overview of meta-analyses. World J Meta-Anal 2017; 5(2): 41-53 [DOI: 10.13105/wjma.v5.i2.41]
URL: https://www.wjgnet.com/2308-3840/full/v5/i2/41.htm
Number Citing Articles
1
Katarzyna Regulska, Miłosz Regulski, Bartosz Karolak, Marcin Michalak, Marek Murias, Beata Stanisz. Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugsPharmacological Research 2019; 147: 104326 doi: 10.1016/j.phrs.2019.104326
2
Liang Gu, Sourav Taru Saha, Jodie Thomas, Mandeep Kaur. Targeting cellular cholesterol for anticancer therapyThe FEBS Journal 2019; 286(21): 4192 doi: 10.1111/febs.15018
3
Katarzyna Regulska, Miłosz Regulski, Bartosz Karolak, Marek Murias, Beata Stanisz. Can cardiovascular drugs support cancer treatment? The rationale for drug repurposingDrug Discovery Today 2019; 24(4): 1059 doi: 10.1016/j.drudis.2019.03.010
4
Md. Mohaimenul Islam, Tahmina Nasrin Poly, Bruno Andreas Walther, Hsuan-Chia Yang, Yu-Chuan (Jack) Li. Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational StudiesCancers 2020; 12(3): 671 doi: 10.3390/cancers12030671
5
I. I. Shaposhnik, V. V. Genkel. Antitumor effects of cardiovascular drugsMeditsinskiy sovet = Medical Council 2020; (14): 56 doi: 10.21518/2079-701X-2020-14-56-62
6
Stephanie Bridgeman, Wendy Northrop, Gaewyn Ellison, Thiru Sabapathy, Phillip Melton, Philip Newsholme, Cyril Mamotte. Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying EnzymesCancers 2019; 11(4): 516 doi: 10.3390/cancers11040516
7
Romina Armando, Diego Mengual G�mez, Daniel Gomez. New drugs are not enough‑drug repositioning in oncology: An updateInternational Journal of Oncology 2020;  doi: 10.3892/ijo.2020.4966
8
Jisha Pillai U, Anindita Ray, Meenu Maan, Mainak Dutta. Repurposing drugs targeting metabolic diseases for cancer therapeuticsDrug Discovery Today 2023; 28(9): 103684 doi: 10.1016/j.drudis.2023.103684
9
Mohammed Batais, Turky Almigbal, Khalid Alotaibi, Abdulaziz Alodhayani, Abdullah Alkhushail, Abdulrahman Altheaby, Mashhor Alhantoushi, Saad Alsaad, Sultan Al Dalbhi, Yasser Alghamdi. Angiotensin converting enzyme inhibitors and risk of lung cancerMedicine 2021; 100(17): e25714 doi: 10.1097/MD.0000000000025714
10
Veronika Piskovatska, Olha Strilbytska, Alexander Koliada, Alexander Vaiserman, Oleh Lushchak. Biochemistry and Cell Biology of Ageing: Part II Clinical ScienceSubcellular Biochemistry 2019; 91: 339 doi: 10.1007/978-981-13-3681-2_13
11
Analia Veitz-Keenan, Thamar Delia Silvestre Calle, Marco Bergamini. Limited Evidence Suggests Metformin Might Be Beneficial to Reduce Head and Neck Cancer Risk and Increase Overall Survival, While Any Benefit With Antiinflammatory Drugs Is InconsistentJournal of Evidence Based Dental Practice 2019; 19(3): 298 doi: 10.1016/j.jebdp.2019.101340